Data / Form D filings / Biopharmaceutical Research Co
Biopharmaceutical Research Co: Form D filings
Biopharmaceutical Research Co, a technology company in Castroville, CA, filed 7 Form D notices with the SEC between 2020 and 2023. The latest, on August 9, 2023, reports $676,065 sold of a $676,065 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11045 COMMERCIAL PARKWAY, Castroville, CA, 95012
- Phone
- (831) 632-0913
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1826834
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | New notice | $676,065 | $676,065 | 1 | Aug 7, 2023 | sec.gov | |
| Jun 20, 2023 | Amendment | $23,156,923 | $23,156,923 | 36 | Jul 5, 2022 | sec.gov | |
| Jul 14, 2022 | New notice | $23,156,923 | $10,192,816 | $12,964,107 | 31 | Jul 5, 2022 | sec.gov |
| Mar 18, 2022 | Amendment | $5,000,000 | $2,535,500 | $2,464,500 | 22 | Feb 8, 2022 | sec.gov |
| Feb 17, 2022 | New notice | $5,000,000 | $1,410,000 | $3,590,000 | 19 | Feb 8, 2022 | sec.gov |
| Dec 20, 2021 | New notice | $85,876 | $85,876 | 1 | Dec 10, 2021 | sec.gov | |
| Oct 2, 2020 | New notice | $3,000,000 | $2,045,000 | $955,000 | 17 | Sep 18, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles Bennett Schumacher | Director | |
| David Bennett Weinmann | Executive Officer | |
| George Bennett Hodgin | Executive Officer, Director | |
| Osagie Bennett Imasogie | Director |
Other technology companies in California that filed recently
- OutLens, Inc. $32,000 · Nov 2, 2026
- ECFX, Inc. offering · Nov 2, 2026
- Redwagon Systems Inc. $1.2 million · Oct 30, 2026
- General Compute Inc. $132.2 million · Oct 30, 2026
- Promptiva Health Inc. offering · Oct 30, 2026
- thenevercompany.ai Inc. $200,000 · Oct 29, 2026
Every Form D from the week of Aug 7, 2023 · All recent filings in California · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Biopharmaceutical Research Co reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.